Tirzepatide, a novel medication, is generating considerable excitement within the scientific community. It operates differently from common diabetes medications, targeting two receptors involved in glucose regulation and appetite . Initial research have demonstrated impressive efficacy in lowering blood glucose in individuals with adult-onset diabe